MED LIFE SA |
End-of-day quote
Other stock markets
|
||
| - RON | - |
|
| 04-03 | Med Life S.A. (BVB:M) acquired an unknown majority stake in Personal Genetics Srl. | CI |
| 02-29 | Med Life S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.49B 539M 738M | Sales 2025 * | 2.78B 602M 823M | Capitalization | 2.21B 478M 655M |
|---|---|---|---|---|---|
| Net income 2024 * | 22M 4.76M 6.52M | Net income 2025 * | 30M 6.5M 8.89M | EV / Sales 2024 * | 0.89 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.8 x |
| P/E ratio 2024 * |
105
x | P/E ratio 2025 * |
70
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Med Life SA
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Mihail Marcu
CEO | Chief Executive Officer | 53 | 06-07-31 |
Adrian Lungu
DFI | Director of Finance/CFO | - | - |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ovidiu Fer
BRD | Director/Board Member | 40 | 20-11-30 |
| Director/Board Member | 68 | 17-08-31 | |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
MedLife S.A. specializes in medical diagnosis and treatment services for enterprises and individuals. The group is active in the fields of orthopedics and traumatology, general and plastic surgery, spinal surgery, gynecology, paediatrics and maternity services.
At the end of 2021, MedLife S.A. operated 80 clinics, 11 multi- and mono-disciplinary hospitals, 34 medical laboratories (near 200 sampling centres), 17 dental clinics and 22 pharmacies located in Romania.
Calendar
2024-05-14
- Q1 2024 Earnings Call
| 1st Jan change | Capi. | |
|---|---|---|
| +13.70% | 80.61B | |
| -29.20% | 70.18B | |
| +9.86% | 29.08B | |
| -11.43% | 16.97B | |
| -0.43% | 16.96B | |
| -0.31% | 15.26B | |
| +3.42% | 12.41B | |
| -30.70% | 11.95B | |
| -6.75% | 11.93B |
